In children whose mother took nucleoside and nucleotide analogues during pregnancy, the benefit from the reduced chance of being infected with HIV is greater than the risk of suffering from side effects.
Lastel, kelle emad kasutasid raseduse ajal nukelosiidi või nukleotiidi analooge, ületab HIV- ga nakatumise ohu vähenemine kõrvaltoimete tekke riski.